...
首页> 外文期刊>Assay and drug development technologies >A facilitated approach to evaluate the inhibitor mode and potency of compounds targeting microsomal prostaglandin e synthase-1.
【24h】

A facilitated approach to evaluate the inhibitor mode and potency of compounds targeting microsomal prostaglandin e synthase-1.

机译:一种简便的方法,用于评估靶向微粒体前列腺素e合酶1的化合物的抑制剂模式和效能。

获取原文
获取原文并翻译 | 示例
           

摘要

Microsomal prostaglandin E(2) synthase-1 (MPGES1) catalyzes the formation of prostaglandin E(2) from the endoperoxide prostaglandin H(2). MPGES1 expression is induced in inflammatory diseases, and this enzyme is regarded as a potential drug target. To aid in the drug discovery effort, a simple method for determination of inhibition mechanism and potency toward both prostaglandin H(2) and glutathione (GSH) has been developed. Using an assay with thiobarbituric acid-based detection, the inhibitory effects of six MPGES1 inhibitors were evaluated. The IC(50) values obtained at three substrate (S) concentrations ([S]K(M)) were used to estimate inhibition modality and inhibition constant values. This facilitated strategy is a useful and general screening method to evaluate the inhibitory effects of new drug compounds.
机译:微粒体前列腺素E(2)合酶1(MPGES1)催化从内过氧化物前列腺素H(2)形成前列腺素E(2)。在炎性疾病中诱导了MPGES1表达,该酶被认为是潜在的药物靶标。为了帮助药物发现,已经开发出一种简单的方法来确定对前列腺素H(2)和谷胱甘肽(GSH)的抑制机理和效力。使用基于硫代巴比妥酸的检测方法,评估了六种MPGES1抑制剂的抑制作用。在三种底物(S)浓度([S] K(M)))下获得的IC(50)值用于评估抑制方式和抑制常数值。这种促进策略是评估新药化合物抑制作用的有用且通用的筛选方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号